
Axonics Modulation Technologies AXNX
Quarterly report 2024-Q3
added 05-16-2026
Axonics Modulation Technologies Accounts Payables 2011-2026 | AXNX
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables Axonics Modulation Technologies
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18.5 M | 9.07 M | 7.65 M | 10.7 M | 5.88 M | 3.44 M | 1.62 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 18.5 M | 1.62 M | 8.11 M |
Quarterly Accounts Payables Axonics Modulation Technologies
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20.1 M | 19.3 M | 15.8 M | 18.5 M | 14.7 M | 12.2 M | 14.7 M | 9.07 M | 9.97 M | 10.2 M | 10.4 M | 7.65 M | 10.5 M | 9.45 M | 11.4 M | 10.7 M | 9.42 M | 10.7 M | 7.44 M | 5.88 M | 4.23 M | 3.18 M | 2.1 M | 3.44 M | 1.98 M | 3.44 M | 3.44 M | 1.62 M | 1.62 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 20.1 M | 1.62 M | 9.07 M |
Accounts Payables of other stocks in the Medical devices industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Avinger
AVGR
|
777 K | - | -20.74 % | $ 369 K | ||
|
Allied Healthcare Products
AHPI
|
1.21 M | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
1.26 M | $ 11.16 | -0.09 % | $ 316 M | ||
|
Apollo Endosurgery
APEN
|
7.42 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
40.9 M | $ 8.27 | 0.55 % | $ 1.24 B | ||
|
Aziyo Biologics
AZYO
|
4.79 M | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
12.6 M | $ 4.33 | 0.23 % | $ 162 M | ||
|
BIOLASE
BIOL
|
6.06 M | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
4.16 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
14.4 M | - | 0.15 % | $ 844 M | ||
|
LENSAR
LNSR
|
19 M | $ 5.86 | 1.03 % | $ 70.1 M | ||
|
Helius Medical Technologies
HSDT
|
1.89 M | $ 2.31 | 6.94 % | $ 50.9 M | ||
|
Cytosorbents Corporation
CTSO
|
2.87 M | $ 0.47 | -0.53 % | $ 29.2 M | ||
|
OrthoPediatrics Corp.
KIDS
|
18.8 M | $ 18.4 | 0.93 % | $ 432 M | ||
|
LivaNova PLC
LIVN
|
97.2 M | $ 73.67 | 1.03 % | $ 4.02 B | ||
|
MiMedx Group
MDXG
|
14.5 M | $ 3.77 | 3.43 % | $ 557 M | ||
|
Delcath Systems
DCTH
|
2.66 M | $ 11.2 | 3.23 % | $ 401 M | ||
|
IRIDEX Corporation
IRIX
|
5.38 M | $ 1.0 | -4.29 % | $ 16.9 M | ||
|
Dynatronics Corporation
DYNT
|
3.4 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
6.5 M | - | - | $ 10.2 M | ||
|
Pulmonx Corporation
LUNG
|
3.9 M | $ 1.54 | 14.55 % | $ 62.7 M | ||
|
Electromed
ELMD
|
2.67 M | $ 37.58 | -2.06 % | $ 318 M | ||
|
Myomo
MYO
|
1.51 M | $ 0.9 | 3.7 % | $ 37.7 M | ||
|
Butterfly Network
BFLY
|
5.44 M | $ 4.42 | 7.8 % | $ 1.09 B | ||
|
Second Sight Medical Products
EYES
|
1.03 M | - | -0.97 % | $ 54.4 M | ||
|
Orthofix Medical
OFIX
|
58.4 M | $ 12.16 | 0.58 % | $ 482 M | ||
|
GBS
GBS
|
1.63 M | - | -0.57 % | $ 7.12 M | ||
|
Sintx Technologies
SINT
|
382 K | $ 2.19 | -0.45 % | $ 6.07 M | ||
|
Profound Medical Corp.
PROF
|
1.56 M | $ 6.95 | 3.19 % | $ 210 M | ||
|
Globus Medical
GMED
|
98.9 M | $ 83.98 | 5.06 % | $ 11.4 B | ||
|
Insulet Corporation
PODD
|
75 M | $ 157.2 | 1.68 % | $ 11.1 B | ||
|
CONMED Corporation
CNMD
|
93.6 M | $ 36.7 | 1.44 % | $ 1.14 B | ||
|
Inspire Medical Systems
INSP
|
36.6 M | $ 44.19 | 3.87 % | $ 1.3 B | ||
|
TransMedics Group
TMDX
|
10.4 M | $ 68.79 | 4.01 % | $ 2.34 B | ||
|
Integer Holdings Corporation
ITGR
|
113 M | $ 91.17 | 0.81 % | $ 3.17 B | ||
|
Invacare Corporation
IVC
|
105 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
228 M | $ 82.96 | 0.97 % | $ 48.5 B |